By Shawn Hauser, Partner; Corey Cox, Associate Attorney
Nov 27, 2019
The FDA issued an update on November 25, 2019, reiterating its position on CBD products in food and dietary supplements. What does this mean for your business?
By Charles Alovisetti, Partner
Nov 18, 2019
With a historic cannabis legislation vote approaching, let’s take a look at the current status of federal law regarding cannabis, other pieces of cannabis-related legislation that have been introduced, and what the MORE Act contains.
By Charles Alovisetti, Jessica Scardina, Ben Leonard, Carl Werner, and Justin Johnson
Nov 18, 2019
HB-1090 is live and Colorado's cannabis industry is officially open to publicly-traded companies and out-of-state investors. Find out what we've learned so far about this brand-new system.
By Elliot Choi, Counsel; Michelle Bodian, Senior Associate Attorney; Charles Alovisetti, Partner
Nov 15, 2019
Will USDA-issued hemp cultivation licenses be transferrable? Let's dive into the USDA interim final rule to find out.
By Charles S. Alovisetti, Partner and Caitlin Wightman, Law Clerk
Nov 8, 2019
The fourth post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post, we focus on jurisdiction choice.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.